Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(8)
DRUG(2)
BIOLOGICAL(2)
OTHER(1)
fludarabine
2 trials
phase_2
danafarber-cancer-institute
busulfex
2 trials
phase_2
danafarber-cancer-institute
tacrolimus
2 trials
phase_2
danafarber-cancer-institute
sirolimus
1 trial
phase_2
danafarber-cancer-institute
Collection of Leukemia Cells
1 trial
not_applicable
danafarber-cancer-institute
Methotrexate
1 trial
phase_2
danafarber-cancer-institute
GM-CSF secreting leukemia vaccine
1 trial
not_applicable
danafarber-cancer-institute
Allogeneic Hematopoietic Stem Cell Transplant
1 trial
phase_2
danafarber-cancer-institute

+2 more interventions

10 unique interventions4 categories

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT01773395Phase 2Terminated
GVAX vs. Placebo for MDS/AML After Allo HSCT
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
PrincipalinvestigatorStart date: 2013-01-08
NCT00809250Phase 1Completed
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
PrincipalinvestigatorStart date: 2008-11-01
NCT00282282Phase 2Completed
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
Graft Versus Host DiseaseGVHD
Principalinvestigator
NCT00426205Not ApplicableCompleted
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
Myelodysplastic Syndrome RAEB-I or RAEB-IIRefractory Acute Myeloid LeukemiaRefractory CML Myeloid Blast Crisis
Principalinvestigator
NCT00809367Not ApplicableCompleted
Collection and Banking of Leukemia Cells MDS/AML
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteGraft vs Host DiseaseMyelodysplastic Syndromes

Worked with same sponsors:

Massachusetts General HospitalNational Institutes of Health (NIH)
Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Similarity Score10%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelomonocytic, ChronicMyelodysplastic Syndromes
Similarity Score10%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesRefractory Acute Myeloid Leukemia
Similarity Score10%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesRefractory Acute Myeloid Leukemia
Similarity Score10%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteRefractory Acute Myeloid LeukemiaMyelodysplastic Syndromes
Similarity Score10%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score10%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteGraft vs Host DiseaseMyelodysplastic Syndromes
Similarity Score10%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesGraft vs Host Disease
Similarity Score10%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT01773395Phase 2PrincipalInvestigator

GVAX vs. Placebo for MDS/AML After Allo HSCT

Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
Terminated
NCT00809250Phase 1PrincipalInvestigator

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Completed
NCT00282282Phase 2PrincipalInvestigator

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Graft Versus Host DiseaseGVHD
Completed
NCT00426205Not ApplicablePrincipalInvestigator

GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies

Myelodysplastic Syndrome RAEB-I or RAEB-IIRefractory Acute Myeloid LeukemiaRefractory CML Myeloid Blast Crisis
Completed
NCT00809367Not ApplicablePrincipalInvestigator

Collection and Banking of Leukemia Cells MDS/AML

Acute Myeloid LeukemiaMyelodysplastic Syndrome
Completed

All 5 trials loaded